GWMIA
SRNE

Global Wealth Management Investment Advisory’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Global Wealth Management Investment Advisory’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-250
Closed -$2K – 536
2020
Q4 		$2K Sell
250
-350
-58% -$2.81K ﹤0.01% 415
2020
Q3 		$7K Buy
600
+50
+9% +$458 ﹤0.01% 311
2020
Q2 		$3K Buy
+550
New +$2.11K ﹤0.01% 495

Other funds holding SRNE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Global Wealth Management Investment Advisory's SRNE Position: Q1 2021 in Review

Global Wealth Management Investment Advisory sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2021, closing a stake of 250 shares — an estimated $2K sold.

Global Wealth Management Investment Advisory first reported a position in SRNE in Q2 2020 and held it in 3 quarters. The position peaked at $7K in Q3 2020. 231 funds tracked by Wall St. Rank hold SRNE as of Q1 2021.

  • Global Wealth Management Investment Advisory reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2021 after selling out during the quarter.
  • Global Wealth Management Investment Advisory sold 250 Sorrento Therapeutics, Inc. shares in Q1 2021, an estimated $2K.
  • Global Wealth Management Investment Advisory first reported a position in Sorrento Therapeutics, Inc. in Q2 2020 and held it in 3 quarters.
  • Global Wealth Management Investment Advisory's Sorrento Therapeutics, Inc. position peaked at $7K in Q3 2020.
  • 231 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2021.

Based on Global Wealth Management Investment Advisory's 13F filing for Q1 2021, filed 17 May 2021.